Tick-borne encephalitis: Acute clinical manifestations and severity in 581 cases from Germany, 2018-2020
- PMID: 36796679
- DOI: 10.1016/j.jinf.2023.02.018
Tick-borne encephalitis: Acute clinical manifestations and severity in 581 cases from Germany, 2018-2020
Erratum in
-
Corrigendum to "Tick-borne encephalitis: Acute clinical manifestations and severity in 581 cases from Germany, 2018-2020" [J Infect 86 (2023) 369-375].J Infect. 2024 Feb;88(2):218. doi: 10.1016/j.jinf.2024.01.007. Epub 2024 Feb 2. J Infect. 2024. PMID: 38316495 No abstract available.
Abstract
Objectives: Tick-borne encephalitis (TBE) is a growing public health problem with an average of 361 cases notified annually to Germany's passive surveillance system since 2001. We aimed to assess clinical manifestations and identify covariates associated with severity.
Methods: We included cases notified 2018-2020 in a prospective cohort study and collected data with telephone interviews, questionnaires to general practitioners, and hospital discharge summaries. Covariates' causal associations with severity were evaluated with multivariable logistic regression, adjusted for variables identified via directed acyclic graphs.
Results: Of 1220 eligible cases, 581 (48%) participated. Of these, 97.1% were not (fully) vaccinated. TBE was severe in 20.3% of cases (children: 9.1%, ≥70-year-olds: 48.6%). Routine surveillance data underreported the proportion of cases with central nervous system involvement (56% vs. 84%). Ninety percent required hospitalization, 13.8% intensive care, and 33.4% rehabilitation. Severity was most notably associated with age (odds ratio (OR): 1.04, 95% confidence interval (CI): 1.02-1.05), hypertension (OR: 2.27, 95%CI: 1.37-3.75), and monophasic disease course (OR: 1.67, 95%CI: 1.08-2.58).
Conclusions: We observed substantial TBE burden and health service utilization, suggesting that awareness of TBE severity and vaccine preventability should be increased. Knowledge of severity-associated factors may help inform patients' decision to get vaccinated.
Keywords: Children; Germany; Health care utilization; Severity; Surveillance; Tick-borne encephalitis.
Copyright © 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Similar articles
-
Clinical manifestations and outcomes of Tick-borne encephalitis: A systematic literature review.Ticks Tick Borne Dis. 2024 Nov;15(6):102407. doi: 10.1016/j.ttbdis.2024.102407. Epub 2024 Nov 4. Ticks Tick Borne Dis. 2024. PMID: 39500220
-
A systematic literature review of the effectiveness of tick-borne encephalitis vaccines in Europe.Vaccine. 2023 Nov 13;41(47):6914-6921. doi: 10.1016/j.vaccine.2023.10.014. Epub 2023 Oct 17. Vaccine. 2023. PMID: 37858450
-
A Retrospective Sero-Surveillance Study for Antibodies Against Tick-Borne Encephalitis Virus in Norway.Viruses. 2025 Feb 20;17(3):291. doi: 10.3390/v17030291. Viruses. 2025. PMID: 40143223 Free PMC article.
-
Incidence of tick-borne encephalitis (TBE) in the pediatric population at the University Hospitals of Strasbourg (HUS) and characterization of confirmed cases.J Neurovirol. 2024 Dec;30(5-6):534-544. doi: 10.1007/s13365-024-01233-8. Epub 2024 Oct 31. J Neurovirol. 2024. PMID: 39480620
-
Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.Hum Vaccin Immunother. 2014;10(10):2819-33. doi: 10.4161/hv.29984. Hum Vaccin Immunother. 2014. PMID: 25483679 Free PMC article.
Cited by
-
Clinical Characteristics of Tick-Borne Encephalitis in Adult Patients: A 10-year Retrospective Study in Stockholm, Sweden.J Infect Dis. 2025 Feb 4;231(1):e195-e205. doi: 10.1093/infdis/jiae463. J Infect Dis. 2025. PMID: 39316686 Free PMC article.
-
Tick-Borne Encephalitis Virus Vaccination among Tourists in a High-Prevalence Area (Italy, 2023): A Cross-Sectional Study.Trop Med Infect Dis. 2023 Nov 2;8(11):491. doi: 10.3390/tropicalmed8110491. Trop Med Infect Dis. 2023. PMID: 37999610 Free PMC article.
-
Does the Vaccination against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates below the WHO Threshold for Endemicity? A Case Study for Germany.Vaccines (Basel). 2024 Oct 12;12(10):1165. doi: 10.3390/vaccines12101165. Vaccines (Basel). 2024. PMID: 39460331 Free PMC article.
-
Tick-Borne Encephalitis Virus Infection in a Two-Year-Old Child Returning from Switzerland (July-August 2023): Is It Time for TBE Immunization of Serbian Travelers?Pathogens. 2024 Nov 18;13(11):1013. doi: 10.3390/pathogens13111013. Pathogens. 2024. PMID: 39599566 Free PMC article.
-
Recovery and sequelae in 523 adults and children with tick-borne encephalitis in Germany.Infection. 2023 Oct;51(5):1503-1511. doi: 10.1007/s15010-023-02023-w. Epub 2023 Apr 6. Infection. 2023. PMID: 37022643 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources